Market Overview

The global pharmaceutical gelatin market is undergoing a period of robust expansion, fueled by rising healthcare demands, innovations in drug delivery systems, and the increasing use of gelatin-based formulations. Pharmaceutical gelatin, a protein derived primarily from collagen obtained from animal sources, plays a critical role as a binding and coating agent in various pharmaceutical applications. It serves as a key ingredient in the production of hard and soft gelatin capsules, tablets, emulsions, and microencapsulation systems.

The demand for pharmaceutical-grade gelatin continues to rise in response to growing needs for effective, stable, and bioavailable drug delivery. As pharmaceutical companies shift toward more patient-centric therapies and oral solid dosage forms, gelatin’s role as a primary pharmaceutical excipient is becoming more vital than ever. The global pharmaceutical gelatin market size is expected to reach USD 3.81 billion by 2032, according to a new study by Polaris Market Research.